Neuroendocrine Tumor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AQST | A | Aquestive Therapeutics, Inc. | 0.55 | |
CRNX | B | Crinetics Pharmaceuticals, Inc. | 1.30 | |
ABUS | D | Arbutus Biopharma Corporation | 2.99 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MNTL | D | Tema Neuroscience and Mental Health ETF | 3.86 | |
HRTS | D | Tema Cardiovascular and Metabolic ETF | 3.79 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 3.04 | |
BBC | B | Virtus LifeSci Biotech Clinical Trials ETF | 2.0 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 1.77 |
Compare ETFs
Related Industries:
Biotechnology
- Neuroendocrine Tumor
A neuroendocrine tumor (NET) is a type of cancer that develops from cells of the neuroendocrine system. This system is made up of cells that release hormones in response to signals from the nervous system. Neuroendocrine tumors can occur anywhere in the body and can be benign (non-cancerous) or malignant (cancerous). Symptoms of NETs vary depending on the location and type of tumor, but may include abdominal pain, diarrhea, weight loss, and fatigue. Treatment options may include surgery, chemotherapy, radiation, and targeted therapy.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles